| Pharmaceutical active ingredients: |
| Doxorubicin Hydrochloride |
| Available forms, composition and doses of Doxorubicin: |
| Injectable; Injection; Doxorubicin Hydrochloride 50 mg |
| Doxorubicin medical category: |
| Human:Antineoplastic agentsCytotoxic chemotherapy |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| L01DB01 - Doxorubicin |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Bryntsalov-A |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Doxopeg | Doxorubicin Hydrochloride | Asofarma de Mexico; Raffo Laboratorios |
| Doxorbin | Doxorubicin Hydrochloride | Bristol-Myers Squibb |
| Doxorubicin | Doxorubicin Hydrochloride | APP Pharmaceuticals |
| Doxorubicin | Doxorubicin Hydrochloride | Bedford Laboratories |
| Doxorubicin | Doxorubicin Hydrochloride | Biomedis Oncology |
| Doxorubicin | Doxorubicin Hydrochloride | David Bull Laboratories |
| Doxorubicin | Doxorubicin Hydrochloride | Ebewe |
| Doxorubicin | Doxorubicin Hydrochloride | Hexal |
| Doxorubicin | Doxorubicin Hydrochloride | Hospira |
| Doxorubicin | Doxorubicin Hydrochloride | Kalbe Farma |